Rapport Therapeutics Inc....

7.52
0.37 (5.17%)
At close: Mar 04, 2025, 9:53 AM

Rapport Therapeutics Common Stock Income Statement

Year FY23 FY22
Revenue n/a n/a
Cost of Revenue 112K 15K
Gross Profit -112K -15K
Operating Income -36.18M -10.37M
Interest Income 2.53M n/a
Pretax Income -34.78M -10.65M
Net Income -34.79M -10.65M
Selling & General & Admin 8.07M 1.24M
Research & Development 28M 9.12M
Other Expenses n/a n/a
Operating Expenses 36.07M 10.35M
Interest Expense n/a 285K
Selling & Marketing Expenses -112K n/a
Cost & Expenses 36.18M 10.37M
Income Tax 10K n/a
Shares Outstanding (Basic) 164.35M 36.58M
Shares Outstanding (Diluted) 164.35M 36.58M
EPS (Basic) -0.21 -0.29
EPS (Diluted) -0.21 -0.29
EBITDA -34.66M -10.35M
Depreciation & Amortization 112K 15K